PSMAddition: Phase 3 Trial of [177lu]Lu-PSMA-617 Plus Standard of Care (SoC) vs. Soc Alone in Patients with Metastatic Hormone-Sensitive Prostate Cancer
H. Kim, S.T. Tagawa, Oliver Sartor, F. Saad, Ashley Reid, Olga V. Sakharova, Felix Y. Feng, K. Fizazi, Michael J. Morris
Topics & Concepts
Prostate cancerMedicineStandard of careOncologyInternal medicineCancerProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsCancer, Lipids, and Metabolism